Minded website uses the following types of cookies: browsing/session, functional, analytics and third party cookies in order to provide a better browsing experience and to collect information about the website. Users can choose whether or not to accept the use of cookies and access the website. By clicking on “Further Information”, the full information notice on the types of cookies will be displayed and you will be able to choose whether or not to accept them whilst browsing on the website.

News and Events

First grand minded meetings held on 8-9 May 2019 in Morego

November 2, 2018 Invited Speaker Prof. Yechezkel (Chezy) Barenholz

On November 2, 2018 Prof. Yechezkel (Chezy) Barenholz will be our invited speaker. 
Prof. Barenholz is head of the Liposome and Membrane Research Lab at the Hebrew University-Hadassah Medical School, Jerusalem, Israel and is also the Daniel G. Miller Professor in Cancer Research at Hebrew University of Jerusalem. He has been on the faculty at Hebrew University since 1968 and has been a visiting Professor at leading Universities around the world. His current research focuses on the development of drugs and nano-drugs based on drug delivery systems (DDS) best exemplified by the anticancer Doxil®, the first liposomal drug as well as the first nano-drug approved by the FDA (1995) and used world-wide. Professor Barenholz is an author of >410 scientific publications, cited as of February 2018 >34,000 times, with h-index of 91. 

November 2, 2018 Invited Speaker Prof. Dan Peer

On November 2, 2018 Prof. Dan Peer will be our invited speaker.
His talk will focus on systemic delivery of RNA molecules using targeted nanocarriers to the immune system. Prof. Peer pioneered the use of RNA interference (RNAi) for in vivo validation of new drug targets within the immune system that has enormous implications in cancer and inflammation.
Professor Dan Peer is the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU). He is also the Chair of Tel Aviv University Cancer Biology Research Center; the biggest Cancer Center in Israel that includes 17 affiliated hospitals and the Managing Director of the SPARK program of Translational Medicine at TAU.


October 8, 2018 "Next Generation Therapeutics and Technological Approaches for Treatment of Neurodevelopmental and Rare Diseases in Children" conference at Tel Aviv University

Blavatniki Center for Drug Delivery
Dr. Shoshy Mizrahy will attend the "Next Generation Therapeutics and Technological Approaches for Treatment of Neurodevelopmental and Rare Diseases in Children" conference at Tel Aviv University. This unique conference focuses on new therapeutic and technological approaches for treating neurodevelopmental disorders and rare diseases that appear in early child development. Autism spectrum disorder (ASD), neuromuscular diseases, cerebral palsy and other rare diseases affect more than 10 percent of all children.

October 4, 2018 Venture Factory @IIT

IIT Technology Transfer and Venture Factory presented the “Proof of Concept (PoC) investment program” of the VV3TT fund - one of the leading Italian technology transfer funds specialized in robotics, automation and medical devices.
This fund invests in IP and high-tech projects generated by Italian research centers and universities, starting from the prototyping phase. The PoC program makes available the first 75k EU investment which allows the realization of the prototype and the participation in an Executive MBA to better define the tech-business model of the initiative.

MINDED Fellows attended the event and met the speakers afterwards.

October 1, 2018 Martina Pannuzzo MSCA Ambassador at MIUR event

On October 1, 2018 our MINDED Fellow Dr Martina Pannuzzo acted as MSCA MINDED Ambassador and presented her academinc path and current research for the MINDED project at the MIUR event in Rapallo.
Her talk focused on "Research and Innovation" and was dedicated to secondary schools students.

September 27, 2018 Invited Speaker Prof. Shawn Chen

Evans blue-based theranostics
On September 28, 2018, Prof. Xiaoyuan (Shawn) Chen was our invited speaker. 
His talk focused on how theranostics (Rx/Dx) aims to develop molecular diagnostic tests and targeted therapeutics with the goals of individualizing treatment by targeting therapy to an individual's specific disease subtype and genetic profile. It can be diagnosis followed by therapy to stratify patients who will likely respond to a given treatment; it can also be therapy followed by diagnosis to monitor early response to treatment and predict treatment efficacy; it is also possible that diagnostics and therapeutics are co-developed (nanotheranostics). This talk will use Evans blue as an example to illustrate how this reversible albumin binder can be suitably for vasculature and lymphatic system imaging, as an enhancer to prolong circulation half-life of drugs for diabetes treatment, radioligand cancer therapy, cancer vaccine and cancer nano prodrug development.

September 26, 2018 MINDED and nPMed Meeting

On September 25 and 26, 2018 the Nanomedicine MINDED Fellows presented their most recent activities and explored potential interactions with the Nanotechnology for Precision Medicine group. The meeting was held at the International Library for Young People Edmondo de Amicis, at the Old Port of Genova.

September 25, 2018 Invited Speaker Dr. Laura Cancedda

Targeting aberrant Cl- homeostasis and GABAAergic transmission in Down syndrome to design innovative therapeutic approaches
In her talk, Dr Lara Cancedda has shown that GABAAR signaling is excitatory rather than inhibitory, in the hippocampi of adult DS mice. Accordingly, hippocampal expression of the cation Cl cotransporter NKCC1 is increased in both trisomic mice and individuals with DS. Notably, NKCC1 inhibition by the FDA-approved diuretic bumetanide restores inhibitory GABAergic signaling, synaptic plasticity and hippocampus-dependent memory in adult DS mice. Based on these findings, a pilot clinical trial will soon start on adult individuals with DS patients. Yet, although repurposing bumetanide for DS is a straightforward therapeutic approach, this may be hindered by bumetanide’s diuretic effect.

September 24, 2018 Communication Training

On September 24, 2018 the Nanomedicine and Molecular Neuroscience MINDED Fellows met with Dr Valeria delle Cave to focus on the best practise to successfully promtote the scientific achievements and activities with the press, media and social networks.

You can follow us on Twitter and learn more about our MINDED Fellows and their activities!

September 12, 2018 Invited Speaker Dr Alexandre Dmitriev

Magnetic, chemical and electrical steering of the nanoscale optical antennas
On September 12, 2018 Prof. Alexandre Dmitriev visited IIT as an Invited Speaker to present his latest research accomplishments. 
Prof. Dmitriev, Full professor at the University of Gothenburg, explained how he combines the plasmonic and magnetic materials (magnetoplasmonics) to devise various nano-optical systems that are controlled by the external magnetic field, including chiral optics, polarizers and biochemosensing surfaces. He also discussed the various low-cost bottom-up nanofabrication methods that we develop to produce large surfaces with optical nanoantennas that can be used in nanophotovoltaics, thermal management and other fields.

September 11, 2018 Invited Speaker Prof. Michel Lombardo

Decomposing heterogeneity within the autisms
In his talk, Prof. Lombrardo highlighted his most recent work using early developmental stratifiers based on early language outcome and social engagement behaviors that dissect and connect multi-level heterogeneity in the autisms. By enhancing the precision of our understanding about multiple types of autisms and specific early developmental mechanisms that affect them, this work will help accelerate progress towards the ideals of personalized medicine.

August 13-23, 2018 CAS SciFinder Future Leaders

On August 13-21, 2018 Alexander Cook took part to the CAS SciFinder Future Leaders at CAS headquarters in Columbus, Ohio. 

At the conclusion of the stay in Columbus, Alex will travel to Boston, MA for the 256th ACS National Meeting & Exposition: Nanoscience, Nanotechnology & Beyond, a platform for scientific professionals to present, publish and discuss the most exciting research discoveries in the field.

June 20 , 2018 Dr Martina Pannuzzo on Report

Report Tv Program

On June 20, 2018 Dr. Martina Pannuzzo was interviewed on the national TV programme REPORT (RAI3 TV) during which she described the research activities she is involved on a daily basis and how she aims to make an impact through the MINDED programme. 

June 14-17, 2018 International Multisensory Research Forum

Visual and somatosensory hand representation through development

On June 16, 2018, our MINDED Fellow Dr Lucilla Cardinali, gave an oral presentation at the 19th International Multisensory Research Forum, during the Developmental Perspective session. The conference took place in Toronto, Canada. 

June 11, 2018 Invited Speaker Prof. S. M. Moghimi

"Innate Immunity and the Nanoscale Matters"

On June 11, 2018, our MINDED Partner, Prof. Moein Moghimi, visited IIT and presented the following seminar: "Innate Immunity and the Nanoscale Matters".
Prof. Moein Moghimi is a Professor of Pharmaceutics and Nanomedicine (School of Pharmacy) at Newcastle University (UK). He is also an Adjoint Professor at the Department of Pharmaceutical Sciences, University of Colorado-Denver Medical Center (USA).

June 11, 2018 Dr. Shadi Farhangrazi Talk

"Making Medicine More Precise!"

Dr. Shadi Farhangrazi's talk took a close look at the science and business factors impacting design, translation, technology transfer and commercialization of pharmaceutical drugs and ways of improving them. We will take a close look at precision medicine, innovations, therapies and medical technologies making a difference and further take a glance at the possible future of medicine and patient care.

Dr. Shadi Farhangrazi, PhD., MS., MBA, Co-Founder and CEO of SMDG is a global business expert, neuroscientist, and biochemist who has facilitated biotechnology business development, and commercialization for many companies world-wide. 

May 25, 2018 Invited Speaker Dr Alessandro Gozzi

"Unravelling the spectrum: convergent fMRI connectivity deficits in mouse models of syndromic autism"

On May 25, 2018 Dr Alessandro Gozzi participated to the group retreat as an Invited Speaker and presented a talk focused on the application of advanced MRI methods to investigate the large-scale neurofunctional architecture of the mouse brain, and describe its modulation by neurodevelopmental and pathological effectors.

Dr Alessandro Gozzi is a Tenure Track Scientist, ERC winner, at IIT Rovereto. 

February 2018 Mcaa Conference General Assembly

The @mariecuriealum Annual Conference and General  Assembly will take place at the KU Leuven, Belgium, on the 2nd and 3rd  February 2018.

Fellows and supervisors can join the Marie Curie Alumni Association  at https://t.co/h2WWnz78em

April 16, 2018 Invited Speaker Prof. Dan Peer

"A universal platform for RNA therapeutics"

On April 16, 2018, our MINDED Partner, Prof. Dan Peer, visited at IIT and gave the following talk  "A universal platform for RNA therapeutics".
Prof. Peer is the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU) funded by the US NIH and the European Union via ERC grant. Prof. Peer is also the Chair of Tel Aviv University Cancer Biology Research Center. He leads the new SPARK program (Center for Translational Medicine) at TAU.

April 9, 2018 Invited Speaker Prof. Didier Letourneur

"Industrial and clinical transfers of research works on biomaterials"

On April 9, 2018 Prof. Didier Letourneur, came to IIT as an Invited Speaker to present to the Minded Fellows a talk focused on industrial and clinical transfers of research works on biomaterials.
Prof. Didier Letourneur is Research Director at CNRS. Since 2014, he is the Director of the Laboratory for Vascular Translational Science affiliated to Inserm and Universities Paris Diderot and Paris North. He also leads the team of Cardiovascular Bioengineering at Bichat Hospital in Paris.


September 29, 2017 I giovani ricercatori che ogni anno abbandonano l'Italia per trasferirsi all'estero


April 24, 2017 IIT alla guida di un progetto europeo da 6 milioni per formare nuove figure di scienziati-imprenditori impegnati nella cura delle malattie del neurosviluppo

Technology Review

L’Europa premia il progetto MINDED coordinato dall’IIT-Istituto Italiano di Tecnologia con un co-finanziamento pari a oltre 3 milioni di euro, per un totale di oltre 6 milioni di investimento, nel quadro delle Marie Skłodowska-Curie Actions (MSCA). 

L’iniziativa permetterà l’avvio di un nuovo piano formativo per giovani scienziati che vogliono identificare terapie innovative per le malattie del neurosviluppo, senza tralasciare gli aspetti sociali ed economici di miglioramento della qualità della vita delle persone.


April 24, 2017 IIT alla guida di un progetto europeo da 6 milioni per formare nuove figure di scienziati-imprenditori impegnati nella cura delle malattie del neurosviluppo

MIT technology review italia

April 20, 2017 Neuroscienze, progetto Ue da 6 milioni per reclutare 24 ricercatori-imprenditori

Il Sole 24 Ore

Formare 24 ricercatori-imprenditori nel settore delle malattie neurologiche dello sviluppo: è l'obiettivo di "Minded", il progetto europeo da 6 milioni di euro co-finanziato dalla Commissione Ue nell'ambito delle Marie Sklodowska Curie Actions e coordinato dall'Italia, con Paolo Decuzzi, dall'Istituto Italiano di Tecnologia (Iit). Al progetto - che prevede l'assunzione di 24 giovani ricercatori da tutto il mondo per svolgere un programma di formazione quadriennale


April, 19 2017 Neurosviluppo, Iit alla guida di un progetto formativo Ue


April 18, 2017 Neuroscienze, progetto da 6 milioni


April 18, 2017 Contro l'autismo va in scena il futuro


April 18, 2017 L'Alma Mater con IIT per la cura delle malattie del neurosviluppo


April 18, 2017 IIT e UNIBO uniti per affrontare le malattie del neurosviluppo

research in italy

April 17, 2017 Giovani “cervelli” per combattere le malattie del cervello. L`Italia è in prima fila


April 15, 2017 Minded: 6 milioni per formare nuove figure di scienziati-imprenditori


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 754490.

© 2017 Minded Project